[Syndrome involving the extrapyramidal motor systems and their drug treatment].
D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D009207:Myoclonus / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D010396:Penicillamine / Q000627:therapeutic use; D013577:Syndrome; D014149:Tranquilizing Agents / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000978:Antiparkinson Agents; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D005680:gamma-Aminobutyric Acid; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D010396:Penicillamine
Syndrome von seiten des extrapyramidalen motorischen Systems und ihre medikamentöse Behandlung